Join us on Apr 28 at 4:30pm ET for a virtual event on topline efficacy and safety data from the Phase 2 study evaluating NDV-01 for the treatment
of HG-NMIBC

Register at www.lifescievents.com/event/relmada

Relmada Therapeutics, Inc.

Unlocking innovative treatments for the improvement of human health

Join us for a virtual KOL event on Apr 28 at 4:30pm ET with Drs. Boris Chertin and Yair Lotan, who will discuss topline data from the Phase 2 study evaluating NDV-01 for HG-NMIBC. The data will be presented at the 2025 AUA meeting..

 Register at www.lifescievents.com/event/relmada

News

View all news

Events

View all events

Event - Apr 26 – Apr 29, 2025

American Urological Association meeting (AUA)

About us